Skip to content
Open·Ingested 11 days ago, not re-verified since. Deadlines can change; confirm on the official page.

Chemical, Biological, Radiological and Nuclear Advance Defense Enabling Network and Clinical Capability (CADENCC)

DEPT OF DEFENSE

Presolicitation · not yet biddable. There is nothing to bid on yet: agencies use this notice type for market research or information. You can respond to get on their radar, but do not budget proposal time for it.

Place of performance: Frederick, MD

View official posting

Free. Verify your email, then we send one reminder only.

Posted
Sep 4, 2026
Closes
No deadline published by the funder

See more open contract opportunities like this

Get alerted when new contract opportunities like this open.

Checking your account…

Free. Everyone sees new listings after 10 days. Unsubscribe anytime.

At a glance

This is a government contract opportunity posted by DEPT OF DEFENSE in the research and development in biotechnology (except nanobiotechnology) category. Work is performed in Frederick, MD.

Classification and identifiers

Industry (NAICS)
Research and Development in Biotechnology (except Nanobiotechnology) (541714)
Product or service (PSC)
National Defense R&D Services; Department of Defense - Military; Experimental Development (AC13)
Solicitation number
W911SR-26-9-CADENCC
Contracting office
W6QK ACC-APG

Who can apply

Work performed in Frederick, MD

About this opportunity

Agency: Department of the Army Office: Army Contracting Command, Edgewood Contracting Division Location: Fort Detrick, MD, USA Program Office: Capability Program Executive for Chemical, Biological, Radiological and Nuclear Defense (CPE CBRN Defense), Joint Project Lead Enabling Technologies (JPL ET) RPP Number: W911SR-26-R-CADENCC Date Issued: 03 September 2026 Proposals Due: 1500 hours, 17 September 2026 1. Through this Request for Project Proposal (RPP), the Capability Program Executive for Chemical, Biological, Radiological and Nuclear Defense’s (CPE CBRN Defense) Joint Project Lead Enabling Technologies (JPL ET) seeks to develop Chemical, Biological, Radiological and Nuclear Advance Defense Enabling Network and Clinical Capability (CADENCC), an enabling capability that will accelerate ...

Refine this search